Product and Service [Axis] Plasma Industry [Member] Pharma Industry [Member] Other Revenue [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Treasury Stock, Common [Member] Retained Earnings [Member] Transaction Type [Axis] Reimbursement Receivables [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] One Pharma Patient Customer [Member] Finite-Lived Intangible Assets by Major Class [Axis] Intangible Assets [Member] Contract Assets [Member] Hosting Implementation [Member] Nature of Expense [Axis] Selling, General And AdministrativeExpense [Member] Legal Entity [Axis] Gamma Innovation LLC [Member] Breakage Revenue [Member] Settlement Revenue [Member] Business Acquisition [Axis] Statistical Measurement [Axis] Maximum [Member] Minimum [Member] Present Value Of Future Cash Paid [Member] Cash Paid And To Be Paid [Member] Stock Consideration Paid And To Be Paid [Member] Noncompete Agreements [Member] Acquired Technologies [Member] Long-Lived Tangible Asset [Axis] Equipment [Member] Software Development [Member] Furniture and Fixtures [Member] Website Costs [Member] Leasehold Improvements [Member] Patents And Trademarks [Member] Technology Platform [Member] Customer Lists And Contracts [Member] Licenses [Member] Non Compete Agreement [Member] Lease Contractual Term [Axis] Office Space [Member] Additional Office Space [Member] Award Type [Axis] Vested Stock Awards And Stock Options Exercised [Member] Restricted Stock [Member] Antidilutive Securities [Axis] Stock Options [Member] Unvested Restricted Stock Options [Member] Receivable Type [Axis] Government Assistance [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets Cash Restricted cash Accounts receivable, net Other receivables Prepaid expenses and other current assets Total current assets Fixed assets, net Intangible assets, net Goodwill Operating lease right-of-use asset Deferred tax asset, net Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable and accrued liabilities Customer card funding Operating lease liability, current portion Other liabilities, current portion Total current liabilities Operating lease liability, long-term portion Other liabilities, long-term portion Total liabilities Commitments and contingencies (Note 9) Stockholders’ equity Preferred stock: $0.001 par value; 25,000,000 shares authorized; none issued and outstanding Common stock; $0.001 par value; 150,000,000 shares authorized, 57,902,271 and 56,021,596 issued at June 30, 2026 and December 31, 2025, respectively Additional paid-in capital Treasury stock at cost, 1,459,689 and 934,708 shares, respectively Retained earnings Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Treasury stock shares Statement [Table] Statement [Line Items] Revenues Total revenues Cost of revenues Gross profit Operating expenses Selling, general and administrative Depreciation and amortization Total operating expenses Income from operations Other income Interest income, net Income before income tax provision Income tax provision Net income Net income per share Basic Diluted Weighted average common shares Basic Diluted Beginning balance, value Beginning balance, shares Beginning balance, shares Stock issued upon vesting of restricted stock Stock issued upon vesting of restricted stock, shares Exercise of stock options Exercise of stock options, shares Stock-based compensation Repurchase of common stock Repurchase of common stock, shares Repurchase of shares for tax withholding Shares withheld for employee taxes, shares Net income Shares withheld for employee taxes Shares withheld for employee taxes, shares Issuance of stock in business combination Ending balance, value Ending balance, shares Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income to net cash provided by operating activities: Stock-based compensation expense Depreciation and amortization Noncash lease expense Change in fair value of contingent consideration Deferred income taxes, net Changes in operating assets and liabilities: Accounts receivable Other receivables Prepaid expenses and other current assets Accounts payable and accrued liabilities Operating lease liability Customer card funding Net cash provided by (used in) operating activities Cash flows from investing activities: Purchase of fixed assets Capitalization of internally developed software Purchase of intangible assets Net assets acquired in business combination Net cash used in investing activities Cash flows from financing activities: Proceeds from exercise of options Payments on other liability Repurchase of shares for tax withholding Repurchase of common stock Net cash (used in) provided by financing activities Net change in cash and restricted cash Cash and restricted cash, beginning of period Cash and restricted cash, end of period Cash and restricted cash reconciliation: Cash Restricted cash Total cash and restricted cash Supplemental cash flow information: Non-cash assets acquired in business combination Non-cash liabilities incurred in business combination Common stock issued in business combination Cash paid for taxes Accounting Policies [Abstract] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT POLICIES Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] ACQUISITION Property, Plant and Equipment [Abstract] FIXED ASSETS, NET Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS, NET Lease LEASE Other Liabilities Disclosure [Abstract] CUSTOMER CARD FUNDING LIABILITY Equity [Abstract] COMMON STOCK Earnings Per Share [Abstract] BASIC AND FULLY DILUTED NET INCOME (LOSS) PER COMMON SHARE Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Related Party Transactions [Abstract] RELATED PARTY Income Tax Disclosure [Abstract] INCOME TAX Insider Trading Arrangements [Line Items] Rule 10b5-1 Arrangement Adopted [Flag] Non-Rule 10b5-1 Arrangement Adopted [Flag] Rule 10b5-1 Arrangement Terminated [Flag] Non-Rule 10b5-1 Arrangement Terminated [Flag] About Paysign, Inc. Principles of Consolidation Subsequent Events Segment Reporting Use of Estimates Cash and Cash Equivalents Restricted Cash Reimbursement Receivables Concentrations of Credit Risk Business Combinations Fixed Assets Intangible Assets Customer Card Funding Fair Value of Financial Instruments Earnings Per Share Revenue and Expense Recognition Operating Leases Stock-Based Compensation Recently Adopted Accounting Pronouncement Recently Issued Accounting Pronouncement Not Yet Adopted Schedule of contingent consideration liability Schedule of purchase consideration Schedule of assets acquired and liabilities assumed Schedule of fair values intangible assets and estimated amortization Schedule of fixed assets Schedule of intangible assets Schedule of operating leases Schedule of lease maturity Schedule of contract liabilities Schedule of computation of basic and fully diluted net income per common share Schedule of anti-dilutive shares Schedule of effective tax rates Beginning January 1, 2026 Change in fair value Settlement (termination of earn-out) Ending, June 30, 2026 Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Number of operating segments Number of reportable segments Cash equivalents Accounts receivable Cash in excess of federally insured limits Concentration risk, percentage Estimated useful life Intangible asset useful life Change in fair value of contingent consideration Contingent consideration liability Actual revenue Fair value gain or loss liability Revenues Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Cash paid upfront Present value of future cash paid Equity consideration Earn-out contingent consideration Total consideration Business Combination, Contingent Consideration Arrangements, Description Identifiable intangible assets Total identifiable net assets Total assets acquired Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Acquired Finite-Lived Intangible Assets [Line Items] Estimated Fair Value Weighted Average Estimated Amortization,(years) Purchase consideration Acquisition measurement period adjustment Amount of earn-out contingent consideration high value Amount of earn-out contingent consideration low value Estimated useful life Transaction costs Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Fixed assets, gross Less: accumulated depreciation Depreciation expense Intangible Asset, Finite-Lived [Table] Finite-Lived Intangible Assets [Line Items] Intangible assets, gross Less: accumulated amortization Finite lived intangible asset useful life Amortization expense Weighted average remaining lease term, operating leases Weighted average discount rate, operating leases 2026 (excluding the six months ended June 30, 2026) 2027 2028 2029 2030 Thereafter Total lease payments Less: Imputed interest Present value of future lease payments Less: current portion of lease liability Long-term portion of lease liability Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Lease term Lease term option to extend Remaining lease term Discount rate Operating lease cost Maintenance expenses Cash paid for operating lease Beginning balance (Decrease) Increase, net Ending balance Customer card funding liability Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, shares outstanding Stock-based compensation expense Proceeds from exercise of stock options Restricted stock awards granted Weighted average grant date fair value, Granted Restricted stock awards granted vest over a period Numerator: Net income Denominator: Weighted average common shares: Denominator for basic calculation Weighted average effects of potentially diluted common stock: Stock options (calculated using the treasury method) Unvested restricted stock grants Denominator for fully diluted calculation Net income per common share: Fully diluted Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive shares: Unvested restricted stock awards Recognized related party expenses Income before income taxes Income tax expense Effective tax rate Accounts and Financing Receivables [Table] Accounts, Notes, Loans and Financing Receivable [Line Items] Reimbursement Receivables [Member] One Pharma Patient Customer [Member] Intangible Assets [Member] Contract Assets [Member] Hosting Implementation [Member] Selling, General And AdministrativeExpense [Member] Gamma Innovation LLC [Member] Breakage Revenue [Member] Settlement Revenue [Member] Acquired Technologies [Member] Website Costs [Member] Patents And Trademarks [Member] Technology Platform [Member] Customer Lists And Contracts [Member] Licenses [Member] Non Compete Agreement [Member] Office Space [Member] Additional Office Space [Member] Plasma Industry [Member] Pharma Industry [Member] Other Revenue [Member] Vested Stock Awards And Stock Options Exercised [Member] Stock Options [Member] Unvested Restricted Stock Options [Member] Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Shares, Outstanding Temporary Equity, Shares Outstanding Stock Repurchased During Period, Value Stock Repurchased During Period, Shares RepurchaseOfSharesForTaxWithholding Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Depreciation, Depletion and Amortization ChangeInFairValueOfContingentConsideration Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Receivables Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Develop Software Payments to Acquire Intangible Assets PaymentsToAcquireAssetsBusinessCombination Net Cash Provided by (Used in) Investing Activities PaymentsOnOtherLiability Payment, Tax Withholding, Share-Based Payment Arrangement Payments for Repurchase of Common Stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Restricted Cash and Cash Equivalents Finite-Lived Intangible Asset, Useful Life Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment LesseeOperatingLeaseLiabilityPaymentDue LessImputedInterest Contract with Customer, Liability Share-Based Payment Arrangement, Noncash Expense Net Income (Loss) Available to Common Stockholders, Basic